FDA approves treatment for refractory multiple myeloma
Accelerated approval has been granted to Xpovio to treat refractory…
Accelerated approval has been granted to Xpovio to treat refractory multiple myeloma by the FDA.
List view / Grid view
Accelerated approval has been granted to Xpovio to treat refractory…
Accelerated approval has been granted to Xpovio to treat refractory multiple myeloma by the FDA.
The FDA has approved the first specific therapy for the…
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...